BVX.L
BiVictriX Therapeutics Plc, a biotechnology company, engages in the development of cancer therapies in the United Kingdom. The company develops Bi-Cygni therapeutics, which are selective for cancer types. Its lead program is BVX001, focuses on acute myeloid leukaemia. The company was formerly known as BiVictriX Plc and changed its name to BiVictriX Therapeutics Plc in August 2021. BiVictriX Therapeutics Plc was founded in 2016 and is headquartered in Macclesfield, the United Kingdom.
Industry
Biotechnology
IPO Date
2021-08-11
Stock Exchange
LSE
Ticker
BVX.L
According to BiVictriX Therapeutics Plc’s latest financial reports and current stock price. The company's current PE Ratio is -2.50. This represents a change of 28.01% compared to the average of -1.95 of the last 4 quarters.
The mean historical PE Ratio of BiVictriX Therapeutics Plc over the last ten years is -19.34. The current -2.50 PE Ratio has changed 1.19% with respect to the historical average. Over the past ten years (40 quarters), BVX.L's PE Ratio was at its highest in in the December 2023 quarter at -1.52. The PE Ratio was at its lowest in in the June 2020 quarter at -9.15.
Average
-19.34
Median
-11.36
Minimum
-44.60
Maximum
-3.00
Discovering the peaks and valleys of BiVictriX Therapeutics Plc PE Ratio, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.
Maximum Annual Increase = 0%
Maximum Annual PE Ratio = -3.00
Minimum Annual Increase = -65.11%
Minimum Annual PE Ratio = -44.60
| Year | PE Ratio | Change |
|---|---|---|
| 2023 | -3.00 | -33.42% |
| 2022 | -4.50 | -46.02% |
| 2021 | -8.34 | -42.02% |
| 2020 | -14.38 | -65.11% |
| 2019 | -41.22 | -7.58% |
The current PE Ratio of BiVictriX Therapeutics Plc (BVX.L) is greater than its 3-year, greater than its 5-year, and greater than its 10-year historical averages
3-year avg
-5.28
5-year avg
-14.29
10-year avg
-19.34
BiVictriX Therapeutics Plc’s PE Ratio is greater than Induction Healthcare Group PLC (-2.78), less than Celadon Pharmaceuticals Plc (-1.16), less than MGC Pharmaceuticals Limited (-0.06), less than Synairgen plc (-0.23), less than Advanced Oncotherapy plc (-0.19), less than Theracryf Plc (-0.69), greater than NetScientific plc (-6.45), less than Destiny Pharma plc (-0.48), less than Cambridge Nutritional Sciences plc (2.96), less than ReNeuron Group plc (-0.01),
| Company | PE Ratio | Market cap |
|---|---|---|
| -2.78 | N/A | |
| -1.16 | N/A | |
| -0.06 | N/A | |
| -0.23 | N/A | |
| -0.19 | N/A | |
| -0.69 | N/A | |
| -6.45 | N/A | |
| -0.48 | N/A | |
| 2.96 | N/A | |
| -0.01 | N/A |
One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like BiVictriX Therapeutics Plc using the financials and key metrics that matter to you in a single view.
The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:
Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.
Get your free trial here.
The easiest way to analyze a company like BiVictriX Therapeutics Plc or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.
Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.
Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.
What is the PE Ratio?
How can you use the PE Ratio?
What is BiVictriX Therapeutics Plc's PE Ratio?
How is the PE Ratio calculated for BiVictriX Therapeutics Plc (BVX.L)?
What is the highest PE Ratio for BiVictriX Therapeutics Plc (BVX.L)?
What is the 3-year average PE Ratio for BiVictriX Therapeutics Plc (BVX.L)?
What is the 5-year average PE Ratio for BiVictriX Therapeutics Plc (BVX.L)?
How does the current PE Ratio for BiVictriX Therapeutics Plc (BVX.L) compare to its historical average?